Temporary Clipping of the Uterine Arteries During Laparoscopic Myomectomy

Sponsor
Charite University, Berlin, Germany (Other)
Overall Status
Completed
CT.gov ID
NCT01530802
Collaborator
(none)
166
2
2
35
83
2.4

Study Details

Study Description

Brief Summary

The aim is to verify, whether intraoperative temporary clipping of the uterine vessels with vascular clips can reduce blood loss significantly.

Condition or Disease Intervention/Treatment Phase
  • Procedure: clipping of uterine arteries during laparoscopic myomectomy
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
166 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Official Title:
Reduction of Intraoperative Blood Loss During Laparoscopic Myomectomy by Temporary Clipping of the Uterine Arteries
Study Start Date :
Jan 1, 2007
Study Completion Date :
Dec 1, 2009

Arms and Interventions

Arm Intervention/Treatment
Experimental: Uterine artery clipped

Both uterine arteries are temporarily clipped by Yasargil clips during laparoscopic myomectomy.

Procedure: clipping of uterine arteries during laparoscopic myomectomy
For laparoscopy standard instruments were used.For vascular clamping we used titan made YASARGIL vessel clips. The patient is put in a 20° Trendelenburg. The surgeon coagulates a 3-4 cm long segment of peritoneum over the ileopsoas muscle. Along the coagulated segment the peritoneum is opened. The surgeon identifies the ureter at its crossing over the common iliac vessels. After medializing the ureter, the pararectal space is opened and the internal iliac artery is identified and dissected till the origin of the uterine artery. The uterine artery is isolated over a distance of about 2 cm. The vascular clip is placed over the uterine artery. Yasargil Clips are applied exclusively in patients of intervention group. Myomectomy is performed in identical fashion in both groups. At the end of myomectomy the vessel clips are removed. The metroplasty is controlled for hemostasis after reopening of the uterine vessels.

No Intervention: Control group

Conventional laparoscopic myomectomy is performed. (No intervention to temporarily occlude uterine arteries is made)

Procedure: clipping of uterine arteries during laparoscopic myomectomy
For laparoscopy standard instruments were used.For vascular clamping we used titan made YASARGIL vessel clips. The patient is put in a 20° Trendelenburg. The surgeon coagulates a 3-4 cm long segment of peritoneum over the ileopsoas muscle. Along the coagulated segment the peritoneum is opened. The surgeon identifies the ureter at its crossing over the common iliac vessels. After medializing the ureter, the pararectal space is opened and the internal iliac artery is identified and dissected till the origin of the uterine artery. The uterine artery is isolated over a distance of about 2 cm. The vascular clip is placed over the uterine artery. Yasargil Clips are applied exclusively in patients of intervention group. Myomectomy is performed in identical fashion in both groups. At the end of myomectomy the vessel clips are removed. The metroplasty is controlled for hemostasis after reopening of the uterine vessels.

Outcome Measures

Primary Outcome Measures

  1. Blood loss during laparoscopic myomectomy [perioperative (preop and postoperative day3)]

    hemoglobin drop transfusion rate

Secondary Outcome Measures

  1. Patency of uterine artery after laparoscopic clipping [perioperative]

    Doppler results of the uterine arteries

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 50 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients are eligible for the study when between 18 and 50 years of age,

  • diagnosed with either symptomatic or asymptomatic leiomyomata, and with desire to keep the uterus, and whose leiomyomata had a minimal combined diameter of ≥ 4 cm.

Exclusion Criteria:
  • patients with severe accompanying medical problems, or

  • with psychiatric illnesses, which jeopardize the participation, or

  • undergoing treatment affecting coagulation and/or hematopoiesis, and

  • patients with suspected malignancy.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Charite University Hospital Berlin Germany 12200
2 Bernd Holthaus Damme Germany

Sponsors and Collaborators

  • Charite University, Berlin, Germany

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT01530802
Other Study ID Numbers:
  • EA4/07906
First Posted:
Feb 10, 2012
Last Update Posted:
Feb 10, 2012
Last Verified:
Jun 1, 2010
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 10, 2012